Early treatment of thrombotic microangiopathy, a rare and serious complication after heart transplant

J Heart Lung Transplant. 2021 Nov;40(11):1481-1482. doi: 10.1016/j.healun.2021.07.025. Epub 2021 Aug 4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Complement Inactivating Agents / administration & dosage
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Heart Transplantation / adverse effects*
  • Humans
  • Male
  • Secondary Prevention / methods*
  • Thrombotic Microangiopathies / etiology
  • Thrombotic Microangiopathies / prevention & control*

Substances

  • Antibodies, Monoclonal, Humanized
  • Complement Inactivating Agents
  • eculizumab